Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Retrospective Multicenter Analysis on 285 Procedures Performed between 2000 and 2020

Blood (2024) 144 (Supplement 1): 2186.

https://doi.org/10.1182/blood-2024-194320

Published: 2024

Journal Articles

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells

Blood (2023) 142 (Supplement 1): 2218.

https://doi.org/10.1182/blood-2023-189574

Published: 2023

Journal Articles

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT

Blood (2023) 142 (Supplement 1): 4975.

https://doi.org/10.1182/blood-2023-179829

Published: 2023

Journal Articles

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated with Expansion and Maturation of NK Cells

Blood (2022) 140 (Supplement 1): 11549–11551.

https://doi.org/10.1182/blood-2022-169136

Published: 2022

Journal Articles

Tagraxofusp Administered Concomitantly with Intrathecal Chemotherapy in Patients with BPDCN who Either Have or are Considered High-risk to Develop CNS Disease is a Safe and Effective Treatment Strategy: An Italian Multicenter Experience

Giulia Rivoli, Germana Beltrami, Anna M. Raiola, Carole Paley, Marcello Riggi, Alida Dominietto, Emanuele Angelucci

Blood (2022) 140 (Supplement 1): 13271–13272.

https://doi.org/10.1182/blood-2022-158985

Published: 2022

Journal Articles

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Alida Dominietto, MD, Stefano Vagge, MD, Susanta Hui, PhD, Carmen Di Grazia, MD, Teresa Lamparelli, MD, Stefania Bregante, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Renzo Corvò, MD, Emanuele Angelucci, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140669

Published: 2020

Journal Articles

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

Patrizia Chiusolo, Sabrina Giammarco, MD PhD, Teresa Lamparelli, Lucia Casarino, Monica Rossi, Alida Dominietto, MD, Anna Maria Raiola, MD, Francesca Gualandi, Carmen Di Grazia, MD, Silvia Betti, MD PhD, Federica Sorà, MD, Elena Rossi, MD PhD, Luciana Teofili, MD, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2019) 134 (Supplement_1): 4490.

https://doi.org/10.1182/blood-2019-126711

Published: 2019

Journal Articles

Outcome of 673 Patients with Hematologic Malignancies Surviving at Least 8 YEARS Post- Allogeneic Transplants: Risk Factors and Quality of Life

Giuseppe Sapienza, MD, Teresa Lamparelli, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Francesca Gualandi, Simona Sica, MD, Elisabetta Metafuni, Emanuele Angelucci, MD, Andrea Bacigalupo, MD

Blood (2019) 134 (Supplement_1): 4601.

https://doi.org/10.1182/blood-2019-131959

Published: 2019

Journal Articles

The Impact of Aminoacid Substitution at Position 116 Class I HLA, in Unrelated Donor Transplants

Patrizia Chiusolo, Teresa Lamparelli, Giuseppe Sapienza, MD, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Sabrina Giammarco, MD PhD, Francesca Gualandi, Elisabetta Metafuni, Monica Rossi, Gessica Minnella, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2019) 134 (Supplement_1): 4620.

https://doi.org/10.1182/blood-2019-130614

Published: 2019

Journal Articles

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

Andrea Bacigalupo, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Carmen Di Grazia, MD, Stefania Bregante, Francesca Gualandi, Maria Teresa Van Lint, MD, Patrizia Chiusolo, MD, Luca Laurenti, MD, Federica Sora, Sabrina Giammarco, MD PhD, Simona Sica, MD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 3351.

https://doi.org/10.1182/blood-2018-99-118850

Published: 2018

Journal Articles

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party

Blood (2018) 132 (Supplement 1): 484.

https://doi.org/10.1182/blood-2018-99-111674

Published: 2018

Journal Articles

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Daniele Avenoso, Stefania Bregante, Anna Maria Raiola, MD, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, MD, Giannoni Livia, Carlo Marani, Carmen Di Grazia, MD, Teresa Lamparelli, Maria Teresa van Lint, Emanuele Angelucci

Blood (2017) 130 (Supplement 1): 5539.

https://doi.org/10.1182/blood.V130.Suppl_1.5539.5539

Published: 2017

Journal Articles

Long Term Outcome of Lenalidomide-Dexamethasone (Rd) Vs Melphalan-Lenalidomide-Prednisone (MPR) Vs Cyclophosphamide-Prednisone-Lenalidomide (CPR) As Induction Followed By Lenalidomide-Prednisone (RP) Vs Lenalidomide (R) As Maintenance in a Community-Based Newly Diagnosed Myeloma Population: Updated Analysis of EMN01 Phase III Study

Blood (2017) 130 (Supplement 1): 901.

https://doi.org/10.1182/blood.V130.Suppl_1.901.901

Published: 2017

Journal Articles

A Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen, Following Unmanipulated Haploidentical Bone Marrow Transplantation, for Acute Myeloid Leukemia: A Multicenter Study

Patrizia Chiusolo, MD, Gesine Bug, Attilio Olivieri, MD, Brune Mats, MD, Nicola Mordini, MD, Emilio Paolo Alessandrino, MD, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Francesca Gualandi, MD, Maria Teresa van Lint, MD, Emanuele Angelucci, MD, Andrea Bacigalupo, MD

Blood (2016) 128 (22): 1234.

https://doi.org/10.1182/blood.V128.22.1234.1234

Published: 2016

Journal Articles

Androgens MAY BOOST Hematologic Response to ANTI-Thymocyte Globulin in Acquired Aplastic Anemia

Sabrina Giammarco, MD, Maria Teresa van Lint, MD, Teresa Lamparelli, MD, Francesca Gualandi, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Stefania Bregante, MD, Simona Sica, Andrea Bacigalupo, MD

Blood (2016) 128 (22): 3900.

https://doi.org/10.1182/blood.V128.22.3900.3900

Published: 2016

Journal Articles

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Carlo Marani, MD, Silvia Morbelli, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Giulia Ferrarazzo, MD, Sandro Nati, MD, Marina Congiu, MD, Stefania Bregante, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3489.

https://doi.org/10.1182/blood.V128.22.3489.3489

Published: 2016

Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3173.

https://doi.org/10.1182/blood.V128.22.3173.3173

Published: 2016

Journal Articles

Final Results of a Multicenter Prospective Phase II Trial of Allogeneic Transplantation for Relapsed/Refractory CD20+ B-Cell Lymphomas: Effect of Rituximab on Graft-Versus-Host Disease-Free/Relapse-Free Survival (GRFS)

Anna Dodero, Francesca Patriarca, Giuseppe Milone, MD, Barbara Sarina, MD, Rosalba Miceli, Anna Paola Iori, Francesco Barretta, Elisabetta Terruzzi, MD, Alberto Mussetti, MD, Massimo Pini, MD, Alberto Bosi, Alida Dominietto, MD, Nicola Cascavilla, MD, Francesco Onida, MD, Franco Narni, Lucia Farina, MD PhD, Alessandro Rambaldi, MD, Paolo Corradini

Blood (2016) 128 (22): 3473.

https://doi.org/10.1182/blood.V128.22.3473.3473

Published: 2016

Journal Articles

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Luca Castagna, MD, Alberto Mussetti, MD, Raynier Devillier, MD PhD, Alida Dominietto, MD, Magda Marcatti, MD, Giuseppe Milone, MD, Francesco Maura, MD, Benedetto Bruno, MD PhD, Sabine Furst, MD, Didier Blaise, MD PhD, Paolo Corradini, MD, Vittorio Montefusco, MD

Blood (2016) 128 (22): 3475.

https://doi.org/10.1182/blood.V128.22.3475.3475

Published: 2016

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Retrospective Multicenter Analysis on 285 Procedures Performed between 2000 and 2020

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated with Expansion and Maturation of NK Cells

Tagraxofusp Administered Concomitantly with Intrathecal Chemotherapy in Patients with BPDCN who Either Have or are Considered High-risk to Develop CNS Disease is a Safe and Effective Treatment Strategy: An Italian Multicenter Experience

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

Outcome of 673 Patients with Hematologic Malignancies Surviving at Least 8 YEARS Post- Allogeneic Transplants: Risk Factors and Quality of Life

The Impact of Aminoacid Substitution at Position 116 Class I HLA, in Unrelated Donor Transplants

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

A Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen, Following Unmanipulated Haploidentical Bone Marrow Transplantation, for Acute Myeloid Leukemia: A Multicenter Study

Androgens MAY BOOST Hematologic Response to ANTI-Thymocyte Globulin in Acquired Aplastic Anemia

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Final Results of a Multicenter Prospective Phase II Trial of Allogeneic Transplantation for Relapsed/Refractory CD20+ B-Cell Lymphomas: Effect of Rituximab on Graft-Versus-Host Disease-Free/Relapse-Free Survival (GRFS)

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only